Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

Summary

The goal of this clinical research study is to find the most effective dose of Targretin® (bexarotene) Gel 1% that can be given to patients as a treatment for alopecia areata. The safety and tolerability of this drug will also be studied. Objectives: 1. Determine the safety and tolerability of Targretin® Gel 1% in the treatment of patients with alopecia areata. 2. Determine the efficacy of Targretin® Gel 1% in the treatment of patients with alopecia areata.

Timeline

Start

2003-05

Primary completion

2006-10

Completion

2007-05

Drugs

Indications